Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard S&P 500 ETF
VOO
$1.01T
| $774M | 0.36% |
1,610,690
+47,831
| +3% | +$21.9M |
|
77
BP
BP
$109B
| $773M | 0.36% |
20,514,923
+1,345,920
| +7% | +$48.3M |
|
78
VanEck Semiconductor ETF
SMH
$72.3B
| $741M | 0.35% |
3,294,175
-116,684
| -3% | -$23.5M |
|
79
Edwards Lifesciences
EW
$51.4B
| $729M | 0.34% |
7,626,878
+498,599
| +7% | +$41.9M |
|
80
Unilever
UL
$137B
| $718M | 0.34% |
12,720,196
+3,093,307
| +32% | +$171M |
|
81
Banco Santander
SAN
$210B
| $686M | 0.32% |
141,764,508
-1,787,102
| -1% | -$7.46M |
|
82
Deere & Co
DE
$165B
| $682M | 0.32% |
1,660,629
+179,171
| +12% | +$68.7M |
|
83
iShares MSCI Europe Financials ETF
EUFN
$4.27B
| $679M | 0.32% |
29,845,183
-121,737
| -0.4% | -$2.57M |
|
84
Sanofi
SNY
$104B
| $678M | 0.32% |
13,947,583
-342,808
| -2% | -$16.7M |
|
85
GSK
GSK
$105B
| $672M | 0.31% |
15,668,260
+631,379
| +4% | +$26M |
|
|
86
Applied Materials
AMAT
$421B
| $670M | 0.31% |
3,248,412
-1,759,133
| -35% | -$323M |
|
87
AstraZeneca
AZN
$249B
| $654M | 0.31% |
4,826,706
+138,609
| +3% | +$18.4M |
|
88
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $624M | 0.29% |
52,693,557
-1,757,503
| -3% | -$17.6M |
|
89
PACCAR
PCAR
$69.7B
| $621M | 0.29% |
5,015,789
+105,747
| +2% | +$11.4M |
|
90
Trane Technologies
TT
$106B
| $620M | 0.29% |
2,065,906
-16,713
| -0.8% | -$4.54M |
|
91
Ingersoll Rand
IR
$34.4B
| $618M | 0.29% |
6,508,431
+146,882
| +2% | +$12.6M |
|
92
Las Vegas Sands
LVS
$29.9B
| $611M | 0.29% |
11,823,584
+559,980
| +5% | +$28.8M |
|
93
Sony
SONY
$135B
| $584M | 0.27% |
34,082,330
+2,288,770
| +7% | +$42.1M |
|
94
AB InBev
BUD
$166B
| $565M | 0.26% |
9,293,386
+293,180
| +3% | +$18.3M |
|
95
iShares Global Healthcare ETF
IXJ
$4.13B
| $495M | 0.23% |
5,312,943
+245,847
| +5% | +$22.2M |
|
96
Crown Castle
CCI
$32.9B
| $494M | 0.23% |
4,669,059
+122,027
| +3% | +$13.3M |
|
97
iShares National Muni Bond ETF
MUB
$45.3B
| $472M | 0.22% |
4,383,882
+337,353
| +8% | +$36.4M |
|
98
iShares Global Tech ETF
IXN
$8.77B
| $460M | 0.21% |
6,151,272
-229,852
| -4% | -$16.5M |
|
99
Medtronic
MDT
$110B
| $430M | 0.2% |
4,928,423
+335,964
| +7% | +$28.7M |
|
100
Wynn Resorts
WYNN
$10.5B
| $415M | 0.19% |
4,060,985
+132,954
| +3% | +$13.2M |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.